MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

Medicineworld.org: First international conference on inflammatory breast cancer

Back to breast cancer blog Blogs list Cancer blog  


Subscribe To Breast Cancer Blog RSS Feed  RSS content feed What is RSS feed?

First international conference on inflammatory breast cancer




The University of Texas M. D. Anderson Cancer Center will hold the first international inflammatory breast cancer (IBC) conference on December 6-7, to bring together internationally recognized breast cancer clinicians and scientists.

Participants will present new clinical discoveries and participate in educational workshops, with the goal of improving diagnosis and management of this rare but deadly disease.



First international conference on inflammatory breast cancer
Massimo Cristofanilli, M.D., associate professor in M. D. Anderson's Department of Breast Medical Oncology and Director of the Morgan Welch Inflammatory Breast Cancer Research Program and Clinic.


During the conference, the new IBC International Consortium will be formalized to develop joint international projects aimed at raising global awareness, increasing education and seeking funding to study the disease. The Consortium will consist of participants from ten countries, including: Australia, Belgium, Egypt, France, Italy, Japan, Spain, Tunisia, the United Arab Emirates and the United Kingdom. Among its first projects, the Consortium plans to establish a database of IBC cases that will include a tissue and serum bank.

"We are assembling scientists from around the world who are passionate about advancing progress against this disease," says Massimo Cristofanilli, M.D., associate professor in M. D. Anderson's Department of Breast Medical Oncology and Director of the Morgan Welch Inflammatory Breast Cancer Research Program and Clinic. "This is the first conference dedicated exclusively to exchanging knowledge and discussing the complexities of IBC. Our goal is to step up the pace of research and education - ultimately saving women's lives."

IBC is a rare, fast-growing and aggressive cancer. It can spread in just a few weeks, and is often mistaken for something other than breast cancer, such as a rash or infection. Survival for women with IBC can be impeded by delays in diagnosis, a lack of expertise in treating IBC and its resistance to therapy with standard chemotherapy. IBC represents up to two percent of all breast cancer cases diagnosed each year in the United States; its prevalence globally is unclear due to its common misdiagnosis.

Research presented at the conference will include an analysis of under-reporting of IBC; a potential new molecular target for prevention and therapy of metastases in IBC; and a new target for IBC therapy showing promise in preclinical phase. For example, one study presents a method that targets the epidermal growth factor receptor, a pathway that plays an important role in tumor growth, mortality and invasion of IBC and which is over expressed in 30 percent of IBC cases; another examines the use of vorinostat, a drug usually used to treat cutaneous T-cell lymphoma, to treat the aggressive cases of IBC that recur on the skin with invasion into the dermal lymphatics.

M. D. Anderson has seen nearly 200 new cases of IBC in the last two years - more than any other institution in the country. In 2006, the institution unveiled the Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, the largest clinic in the world devoted to inflammatory breast cancer research and care. The clinic is composed of a dedicated group of 16 clinical and pre-clinical researchers spanning six divisions, including cancer medicine, diagnostic imaging, pathology/laboratory medicine, prevention, radiation oncology and surgery. Investigators have identified high-impact goals for clinical and pre-clinical studies, all focused on improved patient care through management and discovery.

"We are making great strides for women suffering from IBC," Cristofanilli says. "We are dedicated to disseminating research and information about the disease that will benefit women all over the world in terms of both diagnosis and therapy."


Posted by: Janet    Source




Did you know?
The University of Texas M. D. Anderson Cancer Center will hold the first international inflammatory breast cancer (IBC) conference on December 6-7, to bring together internationally recognized breast cancer clinicians and scientists. Participants will present new clinical discoveries and participate in educational workshops, with the goal of improving diagnosis and management of this rare but deadly disease.

Medicineworld.org: First international conference on inflammatory breast cancer

BREAST CANCER MAIN| Home| Breast cancer news| Common terms| Breast cancer treatment| Breast cancer treatment by stage| Mammogram and breast cancer screening| Surgical treatment of breast cancer| Chemotherapy of breast cancer| Chemo drugs used in breast cancer| Doxorubicin| Cyclophosphamide| Methotrexate| Hormonal therapy of breast cancer| Radiation therapy of breast cancer| Monoclonal therapy| High dose chemotherapy for breast cancer| Recurrent breast cancer| Bisphosphonates and breast cancer| Pregnancy and breast cancer| Risk factors for breast cancer| Risk details| My risk| Comprehensive breast cancer information| Breast cancer statistics| African Americans and breast cancer| Ashkenazi and breast cancer| Asians| Hispanic| Men| Native Americans| Older women and breast cancer| Younger women| Pregnant women and breast cancer| BRCA|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.